Cardiovascular Disease Doctors in Brunswick, ME Accepting Medicare

7 Cardiovascular Disease doctors found. Showing 1 - 7

Scott D Mills, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 121 Medical Center Drive, Suite 3100, Brunswick, ME 04011 Phone: 207-729-7939    Fax: 207-725-4717

Dr. Puneet Victor Bansal, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Dr Ste 3100, Brunswick, ME 04011 Phone: 207-406-7310

Paul R Burns, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Drive, Suite 3100, Brunswick, ME 04011 Phone: 207-729-7939    Fax: 207-725-4717

Ellen M Simon, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Dr, Suite 3100, Brunswick, ME 04011 Phone: 207-729-7939    Fax: 207-725-4717

Matthew W Corbett, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Dr Ste 3100, Brunswick, ME 04011 Phone: 207-844-4878    Fax: 207-725-4717

Benjamin A Lowenstein, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Drive, Suite 3100, Brunswick, ME 04011 Phone: 207-729-7939    Fax: 207-725-4717

Enrique J Rivas, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Dr, Suite 3100, Brunswick, ME 04011 Phone: 207-729-7939    Fax: 207-725-4717

News Archive

Identical twins shine new light on genetic cause of juvenile arthritis

Identical twin toddlers who presented with severe arthritis helped scientists to identify the first gene mutation that can single-handedly cause a juvenile form of this inflammatory joint disease.

Antidepressants can potentially prevent depression in people at high risk

Antidepressants are well established for use in the treatment of depression, but new research by Keele University has shown that they can potentially prevent the condition in people who are at high risk of developing depressive illness.

InVivo files biopolymer scaffold IDE with FDA to initiate spinal cord injury clinical trial

InVivo Therapeutics today announced that the Company has submitted an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) for a proprietary biopolymer scaffolding device to protect and support spinal tissue and prevent secondary injury, including inflammation and glial scarring, following traumatic spinal cord injury.

BUSM researchers participate in five-year program to develop biomarkers for small vessel disease

To better predict, study and diagnose small vessel disease in the brain and its role in vascular contributions to cognitive impairment and dementia (VCID), Boston University School of Medicine has been selected to participate in MarkVCID, a consortium designed to accelerate the development of new and existing biomarkers for small vessel VCID.

Read more Medical News

› Verified 9 days ago